Podofilox
Podofilox (podophyllotoxin) is an antimitotic agent derived from the mayapple plant that inhibits microtubule assembly by binding to tubulin, thereby arresting cell division at metaphase and inducing apoptosis in rapidly dividing cells. It is used topically for the treatment of external genital and perianal warts (condylomata acuminata) caused by human papillomavirus.
Moleküler Ağırlık
414,4000 g/mol
LogP
2,00
TPSA
92,70 Ų
Lipinski RO5
Geçer
Terapötik Alanlar
Etki Mekanizması
Applied directly to the skin or mucous membranes, where it exerts its therapeutic effect locally at the site of application with minimal systemic absorption.
Pharmacokinetics (PK)
Pharmacodynamics (PD)
Applied directly to the skin or mucous membranes, where it exerts its therapeutic effect locally at the site of application with minimal systemic absorption.
2D Yapı
Cite this structure
Embed this structure
SMILES
COc1cc([C@@H]2c3cc4c(cc3[C@H](O)[C@H]3COC(=O)[C@H]23)OCO4)cc(OC)c1OC
InChI
InChI=1S/C22H22O8/c1-25-16-4-10(5-17(26-2)21(16)27-3)18-11-6-14-15(30-9-29-14)7-12(11)20(23)13-8-28-22(24)19(13)18/h4-7,13,18-20,23H,8-9H2,1-3H3/t13-,18+,19-,20-/m0/s1
Molecular Formula
C22H22O8
HBD / HBA
1 / 8
Döndürülebilir Bağlar
4
Ağır Atomlar
30
No targets recorded
Target interaction data is not yet available for this drug.
No interactions recorded
Drug interaction data is not yet available for this compound.
No side effects recorded
Side effect data is not yet available for this drug.
Sıkça Sorulan Sorular
Podofilox (podophyllotoxin) is an antimitotic agent derived from the mayapple plant that inhibits microtubule assembly by binding to tubulin, thereby arresting cell division at metaphase and inducing apoptosis in rapidly dividing cells. It is used topically for the treatment of external genital and perianal warts (condylomata acuminata) caused by human papillomavirus.
Applied directly to the skin or mucous membranes, where it exerts its therapeutic effect locally at the site of application with minimal systemic absorption.
Yes, Podofilox is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.
References & Data Sources
- ChEMBL — European Bioinformatics Institute (EBI). CHEMBL61. Open-access bioactivity database.
- PubChem — National Center for Biotechnology Information (NCBI). CID 10607. Chemical information database.
Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.
Embed This Widget
Add the script tag and a data attribute to embed this widget.
<script src="https://cdn.jsdelivr.net/npm/drugfyi-embed@1/dist/embed.min.js" defer></script>
<div data-drugfyi="drug" data-slug="podofilox"></div>Embed via iframe for maximum compatibility.
<iframe src="https://drugfyi.com/iframe/drug/podofilox/" width="420" height="400" frameborder="0" style="border:0;border-radius:10px;max-width:100%" loading="lazy"></iframe>Paste this URL in WordPress, Medium, or any oEmbed-compatible platform.
https://drugfyi.com/drug/podofilox/Add a dynamic SVG badge to your README or docs.
[](https://drugfyi.com/drug/podofilox/)Use the native HTML custom element.
<script src="https://cdn.jsdelivr.net/npm/drugfyi-embed@1/dist/embed.min.js" defer></script>
<drugfyi-drug slug="podofilox"></drugfyi-drug>